Pentraxin-3 predicts functional recovery and 1-year major adverse cardiovascular events after rehabilitation of cardiac surgery patients.

Authors
Publication date
1 January 2012
Publisher

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Florence Research

    redirect
    oaioai:flore.unifi.it:2158/680727
    Last time updated on 17/04/2020